{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T13:17:36Z","timestamp":1789996656634,"version":"4.0.1"},"reference-count":58,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,24]],"date-time":"2016-03-24T00:00:00Z","timestamp":1458777600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Brasileira de Reumatologia (English Edition)"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.rbre.2016.03.009","type":"journal-article","created":{"date-parts":[[2016,6,2]],"date-time":"2016-06-02T09:14:31Z","timestamp":1464858871000},"page":"451-457","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["IL33 in rheumatoid arthritis: potential contribution to pathogenesis"],"prefix":"10.1016","volume":"56","author":[{"given":"Rafaela Bicalho Viana","family":"Macedo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana Maria","family":"Kakehasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus Vinicius","family":"Melo de Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rbre.2016.03.009_bib0005","series-title":"Rheumatoid arthritis","first-page":"3","article-title":"Genetics of rheumatoid arthritis","author":"Gregersen","year":"2006"},{"key":"10.1016\/j.rbre.2016.03.009_bib0010","series-title":"Samter's immunologic diseases","first-page":"427","article-title":"Rheumatoid arthritis","author":"Gulko","year":"2001"},{"key":"10.1016\/j.rbre.2016.03.009_bib0015","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature01661","article-title":"Evolving concepts of rheumatoid arthritis","volume":"423","author":"Firestein","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.rbre.2016.03.009_bib0020","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.0105-2896.2009.00859.x","article-title":"Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis","volume":"233","author":"Bartok","year":"2010","journal-title":"Immunol Rev"},{"key":"10.1016\/j.rbre.2016.03.009_bib0025","first-page":"85","article-title":"Evidence for activated peripheral blood T-cells in rheumatoid arthritis","volume":"11","author":"Keystone","year":"1983","journal-title":"J Rheumatol Suppl"},{"key":"10.1016\/j.rbre.2016.03.009_bib0030","doi-asserted-by":"crossref","first-page":"9203","DOI":"10.1073\/pnas.97.16.9203","article-title":"T cell homeostasis in patients with rheumatoid arthritis","volume":"97","author":"Koetz","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.rbre.2016.03.009_bib0035","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jaut.2007.07.002","article-title":"Disturbances in B- and T-cell homeostasis in rheumatoid arthritis: suggested relationships with antigen-driven immune responses","volume":"29","author":"Fekete","year":"2007","journal-title":"J Autoimmun"},{"key":"10.1016\/j.rbre.2016.03.009_bib0040","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.autrev.2007.02.017","article-title":"B cells in rheumatoid arthritis","volume":"7","author":"Bugatti","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.rbre.2016.03.009_bib0045","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nri2094","article-title":"Cytokines in the pathogenesis of rheumatoid arthritis","volume":"7","author":"McInnes","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.rbre.2016.03.009_bib0050","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.3346\/jkms.2011.26.9.1132","article-title":"Measurement of interleukin-33 (IL-33) and IL-33 receptors (sST2 and ST2L) in patients with rheumatoid arthritis","volume":"26","author":"Hong","year":"2011","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.rbre.2016.03.009_bib0055","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","article-title":"IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines","volume":"23","author":"Schmitz","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.rbre.2016.03.009_bib0060","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.4049\/jimmunol.0902685","article-title":"IL-33 exacerbates autoantibody-induced arthritis","volume":"184","author":"Xu","year":"2010","journal-title":"J Immunol"},{"issue":"Suppl. 2","key":"10.1016\/j.rbre.2016.03.009_bib0065","doi-asserted-by":"crossref","first-page":"i101","DOI":"10.1136\/annrheumdis-2011-200589","article-title":"IL-33: a Janus cytokine","volume":"71","author":"Liew","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rbre.2016.03.009_bib0070","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nri2692","article-title":"Disease-associated functions of IL-33: the new kid in the IL-1 family","volume":"10","author":"Liew","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.rbre.2016.03.009_bib0075","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1189\/jlb.1207830","article-title":"Induction of IL-33 expression and activity in central nervous system glia","volume":"84","author":"Hudson","year":"2008","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.rbre.2016.03.009_bib0080","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.jaci.2008.04.005","article-title":"A novel IL-1 family cytokine, IL-33, potently activates human eosinophils","volume":"121","author":"Cherry","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.rbre.2016.03.009_bib0085","doi-asserted-by":"crossref","first-page":"6930","DOI":"10.1073\/pnas.95.12.6930","article-title":"T1\/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function","volume":"95","author":"L\u00f6hning","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.rbre.2016.03.009_bib0090","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/intimm\/dxn060","article-title":"IL-33 amplifies both T(h)1-and T(h)2-type responses through its activity on human basophils, allergen-reactive T(h)2 cells, iNKT and NK Cells","volume":"20","author":"Smithgall","year":"2008","journal-title":"Int Immunol"},{"key":"10.1016\/j.rbre.2016.03.009_bib0095","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1164\/ajrccm.164.2.2008120","article-title":"Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation","volume":"164","author":"Oshikawa","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rbre.2016.03.009_bib0100","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/labinvest.2008.82","article-title":"Interleukin-33 enhances adhesion, CD11b expression and survival in human eosinophils","volume":"88","author":"Suzukawa","year":"2008","journal-title":"Lab Invest"},{"key":"10.1016\/j.rbre.2016.03.009_bib0105","doi-asserted-by":"crossref","first-page":"9773","DOI":"10.1073\/pnas.0901206106","article-title":"The cytokine interleukin-33 mediates anaphylactic shock","volume":"106","author":"Pushparaj","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.rbre.2016.03.009_bib0110","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1002\/eji.200838575","article-title":"The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-gamma production","volume":"39","author":"Bourgeois","year":"2009","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.rbre.2016.03.009_bib0115","doi-asserted-by":"crossref","first-page":"10913","DOI":"10.1073\/pnas.0801898105","article-title":"IL-33 exacerbates antigen induced arthritis by activating mast cells","volume":"105","author":"Xu","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.rbre.2016.03.009_bib0120","doi-asserted-by":"crossref","first-page":"18660","DOI":"10.1073\/pnas.0705939104","article-title":"IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells","volume":"104","author":"Ali","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.rbre.2016.03.009_bib0125","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1189\/jlb.0407200","article-title":"IL-33 induces IL-13 production by mouse mast cells independently of IgE-Fc epsilon RI signals","volume":"82","author":"Ho","year":"2007","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.rbre.2016.03.009_bib0130","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.cyto.2007.09.013","article-title":"Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells","volume":"40","author":"Moulin","year":"2007","journal-title":"Cytokine"},{"key":"10.1016\/j.rbre.2016.03.009_bib0135","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.4049\/jimmunol.179.4.2051","article-title":"Cutting edge: the ST2 ligand IL-33 potently activates and drives maturation of human mast cells","volume":"179","author":"Allakhverdi","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.rbre.2016.03.009_bib0140","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1172\/JCI30634","article-title":"IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system","volume":"117","author":"Sanada","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.rbre.2016.03.009_bib0145","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1046\/j.1365-2745.2002.01494.x","article-title":"Expression and function of the ST2 gene in a murine model of allergic airway inflammation","volume":"32","author":"Oshikawa","year":"2002","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.rbre.2016.03.009_bib0150","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.4049\/jimmunol.181.7.4780","article-title":"IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4","volume":"181","author":"Kurowska-Stolarska","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.rbre.2016.03.009_bib0155","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nri1630","article-title":"Negative regulation of toll-like receptor-mediated immune responses","volume":"5","author":"Liew","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.rbre.2016.03.009_bib0160","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/nm.2156","article-title":"Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection","volume":"16","author":"Alves-Filho","year":"2010","journal-title":"Nat Med"},{"key":"10.1016\/j.rbre.2016.03.009_bib0165","doi-asserted-by":"crossref","first-page":"125","DOI":"10.14712\/18059694.2016.71","article-title":"The counter-regulation of atherogenesis: a role for interleukin-33","volume":"53","author":"Kunes","year":"2010","journal-title":"Acta Med (Hradec Kralove)"},{"key":"10.1016\/j.rbre.2016.03.009_bib0170","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.pharmthera.2011.02.005","article-title":"The IL33\/ST2 pathway \u2013 a new therapeutic target in cardiovascular disease","volume":"131","author":"Miller","year":"2011","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.rbre.2016.03.009_bib0175","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/rheumatology\/kep402","article-title":"Serum levels of IL-33 and soluble ST2 and their association with disease activity in systemic lupus erythematosus","volume":"49","author":"Mok","year":"2010","journal-title":"Rheumatology (Oxf)"},{"key":"10.1016\/j.rbre.2016.03.009_bib0180","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3109\/03009742.2012.735700","article-title":"Serum levels of IL-33 and its receptor ST2 are elevated in patients with ankylosing spondylitis","volume":"42","author":"Li","year":"2013","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.rbre.2016.03.009_bib0185","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1136\/annrheumdis-2012-201553","article-title":"Increased serum IL-33 levels may indicate vascular involvement in systemic sclerosis","volume":"72","author":"Terras","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rbre.2016.03.009_bib0190","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.cyto.2013.03.007","article-title":"Soluble ST2 as a marker of disease activity in systemic juvenile idiopathic arthritis","volume":"62","author":"Ishikawa","year":"2013","journal-title":"Cytokine"},{"issue":"3 Suppl 77","key":"10.1016\/j.rbre.2016.03.009_bib0195","first-page":"6","article-title":"Serum IL-33 levels and skin mRNA expression in Beh\u00e7et's disease","volume":"31","author":"Hamzaoui","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rbre.2016.03.009_bib0200","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1136\/annrheumdis-2012-201309","article-title":"IL-33 is overexpressed in the inflamed arteries of patients with giant cell arteritis","volume":"72","author":"Ciccia","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rbre.2016.03.009_bib0205","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00403-012-1268-7","article-title":"Elevated serum interleukin-33 levels in patients with Henoch-Sch\u00f6nlein purpura","volume":"305","author":"Chen","year":"2013","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.rbre.2016.03.009_bib0210","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1165\/rcmb.2010-0516OC","article-title":"Infection with influenza virus induces IL-33 in murine lungs","volume":"45","author":"Le Goffic","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.rbre.2016.03.009_bib0215","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/mp.2009.10","article-title":"Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease","volume":"14","author":"Chapuis","year":"2009","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.rbre.2016.03.009_bib0220","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s10875-011-9622-7","article-title":"Characterization of interleukin-33 and soluble ST2 in serum and their association with disease severity in patients with chronic kidney disease","volume":"32","author":"Bao","year":"2012","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.rbre.2016.03.009_bib0225","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1002\/eji.201141947","article-title":"IL-33 attenuates EAE by suppressing IL-17 and IFN-production and inducing alternatively activated macrophages","volume":"42","author":"Jiang","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.rbre.2016.03.009_bib0230","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1016\/j.ajpath.2012.03.009","article-title":"The ST2 pathway is involved in acute pancreatitis: a translational study in humans and mice","volume":"180","author":"Ouziel","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.rbre.2016.03.009_bib0235","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/jid.2010.366","article-title":"High levels of soluble ST2 and low levels of IL-33 in sera of patients with HIV infection","volume":"131","author":"Miyagaki","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.rbre.2016.03.009_bib0240","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1089\/jir.2011.0109","article-title":"Serum IL-33 levels are associated with liver damage in patients with chronic hepatitis B","volume":"32","author":"Wang","year":"2012","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.rbre.2016.03.009_bib0245","doi-asserted-by":"crossref","first-page":"819636","DOI":"10.1155\/2012\/819636","article-title":"Serum IL-33 levels are associated with liver damage in patients with chronic hepatitis C","volume":"2012","author":"Wang","year":"2012","journal-title":"Mediat Inflamm"},{"issue":"Suppl. 1","key":"10.1016\/j.rbre.2016.03.009_bib0250","doi-asserted-by":"crossref","first-page":"i43","DOI":"10.1136\/ard.2009.120113","article-title":"Role of interleukin 33 in human immunopathology","volume":"69","author":"Murphy","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rbre.2016.03.009_bib0255","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1126\/science.1073176","article-title":"Mast cells: a cellular link between autoantibodies and inflammatory arthritis","volume":"297","author":"Lee","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.rbre.2016.03.009_bib0260","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1136\/ard.2009.122655","article-title":"IL-33 induces neutrophil migration in rheumatoid arthritis and is a target of anti-TNF therapy","volume":"69","author":"Verri","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.rbre.2016.03.009_bib0265","first-page":"A28","article-title":"Interleukin-33 suppresses experimental arthritis through promoting Foxp3+ regulatory T-cells and type-2 immune responses in mice","volume":"73","author":"Biton","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rbre.2016.03.009_bib0270","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/art.24305","article-title":"Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis","volume":"60","author":"Palmer","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rbre.2016.03.009_bib0275","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3899\/jrheum.090492","article-title":"Increased levels of interleukin 33 in sera and synovial fluid from patients with active rheumatoid arthritis","volume":"37","author":"Matsuyama","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rbre.2016.03.009_bib0280","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.cyto.2011.12.010","article-title":"Increased levels of interleukin-33 associated with bone erosion and interstitial lung diseases in patients with rheumatoid arthritis","volume":"58","author":"Xiangyang","year":"2012","journal-title":"Cytokine"},{"key":"10.1016\/j.rbre.2016.03.009_bib0285","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1136\/ard.2010.134684","article-title":"State-of-the-art: rheumatoid arthritis","volume":"69","author":"McInnes","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rbre.2016.03.009_bib0290","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2147\/DDDT.S25426","article-title":"Kinase inhibitors: a new class of antirheumatic drugs","volume":"6","author":"Kyttaris","year":"2012","journal-title":"Drug Des Dev Ther"}],"container-title":["Revista Brasileira de Reumatologia (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2255502116300037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2255502116300037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T13:53:01Z","timestamp":1536673981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2255502116300037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":58,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S2255502116300037"],"URL":"https:\/\/doi.org\/10.1016\/j.rbre.2016.03.009","relation":{},"ISSN":["2255-5021"],"issn-type":[{"value":"2255-5021","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL33 in rheumatoid arthritis: potential contribution to pathogenesis","name":"articletitle","label":"Article Title"},{"value":"Revista Brasileira de Reumatologia (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rbre.2016.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.rbr.2016.01.006","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Editora Ltda.","name":"copyright","label":"Copyright"}]}}